These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 3613889)

  • 21. Impact of education by clinical pharmacists on physician ambulatory care prescribing of generic versus brand-name drugs.
    Erramouspe J
    DICP; 1989 Oct; 23(10):770-3. PubMed ID: 2815852
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic substitution--usurpation of the physician's prerogative.
    Ballin JC
    JAMA; 1987 Jan 23-30; 257(4):528-9. PubMed ID: 3795436
    [No Abstract]   [Full Text] [Related]  

  • 23. The generic prescribing issue.
    Brater DC; Pettinger WA
    Ann Intern Med; 1980 Mar; 92(3):426-7. PubMed ID: 7356238
    [No Abstract]   [Full Text] [Related]  

  • 24. Prescription for fairness: a new approach to tort liability of brand-name and generic drug manufacturers.
    Rostron A
    Duke Law J; 2011 Feb; 60(5):1123-91. PubMed ID: 21365961
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The brand name versus generic controversy: Is there a segment of the pharmaceutical industry that produces drugs of higher quality?
    Marsh DA; Hoar ME
    Contemp Pharm Pract; 1982; 5(2):130-5. PubMed ID: 10317245
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patient consent in drug substitution laws.
    Archambault GF
    Hosp Formul; 1975 Nov; 10(11):558. PubMed ID: 10237821
    [No Abstract]   [Full Text] [Related]  

  • 27. Consumer price differentials between generic and brand name prescriptions.
    Gumbhir AK; Rodowskas CA
    Am J Public Health; 1974 Oct; 64(10):977-82. PubMed ID: 4213009
    [No Abstract]   [Full Text] [Related]  

  • 28. Drug substitution--boon to consumers versus legal trap for the professional.
    Brennan BJ
    J Leg Med (N Y); 1976 Mar; 4(3):20-5. PubMed ID: 1083405
    [No Abstract]   [Full Text] [Related]  

  • 29. Liability for generic substitution.
    Gordinier RH
    Postgrad Med; 1987 Feb; 81(3):13, 16, 21. PubMed ID: 3809065
    [No Abstract]   [Full Text] [Related]  

  • 30. Generic prescribing and the drug industry.
    Br Med J (Clin Res Ed); 1982 Mar; 284(6320):919. PubMed ID: 6802347
    [No Abstract]   [Full Text] [Related]  

  • 31. The debate over substitution policy. Its evolution and scientific basis.
    Schwartz LL
    Am J Med; 1985 Aug; 79(2B):38-44. PubMed ID: 3898831
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reconsidering the scope of US state laws allowing pharmacist substitution of generic drugs.
    Darrow JJ; Chong JE; Kesselheim AS
    BMJ; 2020 Jun; 369():m2236. PubMed ID: 32576554
    [No Abstract]   [Full Text] [Related]  

  • 33. Substitution--the New York State experience.
    DeNuzzo RV
    Med Mark Media; 1981 Jan; 16(1):25-9. PubMed ID: 10249801
    [No Abstract]   [Full Text] [Related]  

  • 34. Forces and direction of drug product selection legislation.
    Stewart JE
    Med Mark Media; 1979 Jun; 14(6):34-6, 38-9. PubMed ID: 10242281
    [No Abstract]   [Full Text] [Related]  

  • 35. Economic aspects of drug substitution.
    Salehi H; Schweitzer SO
    Health Care Financ Rev; 1985; 6(3):59-68. PubMed ID: 10311162
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mislabeling and patient liability issues for pharmacists.
    Fink JL
    Contemp Pharm Pract; 1981; 4(4):207-10. PubMed ID: 10256892
    [TBL] [Abstract][Full Text] [Related]  

  • 37. FDA drug list: key to generic substitution.
    FDA Consum; 1979 Feb; 13(1):15-7. PubMed ID: 10308816
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Generic drug substitution].
    Tamir O; Halkin H; Shemer J
    Harefuah; 2006 Sep; 145(9):691-5, 701. PubMed ID: 17078434
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Generic prescribing in Pennsylvania.
    Hayes AH
    Pa Med; 1977 Mar; 80(3):28-9. PubMed ID: 846745
    [No Abstract]   [Full Text] [Related]  

  • 40. Status of generic substitution: problematic drug classes reviewed.
    Ross MB
    Hosp Formul; 1989 Aug; 24(8):441-4, 447-9. PubMed ID: 10294356
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.